v3.25.4
Condensed Consolidated Statements of Cash Flows
4 Months Ended 6 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2025
HKD ($)
Jun. 30, 2024
HKD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2024
HKD ($)
Dec. 31, 2023
HKD ($)
Cayson Acquisition Corp [Member]                  
Cash flows from operating activities:                  
Net income $ (91,197)       $ 475,489 $ 1,203,841      
Adjustment to reconcile net income to cash used in operating activities:                  
Interest earned on investments held in Trust Account (56,234)       (752,079) (1,924,226) $ (752,079)    
Change in operating assets and liabilities:                  
Accrued offering costs 65,000       65,000 10,000      
Accrued expenses 29,250       38,025 266,179      
Change in prepaid expenses (205,421)       (195,653) 66,850      
Net cash provided by operating activities (258,602)       (369,218) (377,356)      
Cash flows from investing activities:                  
Extension payments held in escrow account         (600,000)      
Investment of cash in Trust Account (60,000,000)              
Net cash (used in) provided by investing activities (60,000,000)       (60,000,000) (600,000)      
Cash flows from financing activities:                  
Proceeds from promissory note         300,000      
Proceeds from promissory note - related party         300,000      
Proceeds from issue of shares 1,450              
Proceeds from initial public offering 60,000,000       60,000,000 60,000,000    
Proceeds from private placement 2,300,000       2,300,000      
Payment of underwriter’s discount (1,200,000)       (1,200,000)      
Borrowings from related party 261,317       261,317      
Repayment of borrowings from related party (261,317)       (261,317)      
Payment of offering costs (266,978)              
Net cash provided by (used in) financing activities 60,834,472       60,834,472 600,000      
Net change in cash, cash equivalents and restricted cash 575,870       465,254 (377,356)      
Cash, cash equivalents and restricted cash at beginning of the year $ 465,254     465,254      
Cash, cash equivalents and restricted cash at end of the year 575,870       465,254 87,898 465,254    
Cash, cash equivalents and restricted cash:                  
Cash and cash equivalents         465,254 87,898 465,254    
Supplementary cash flows information:                  
Issuance of founder shares in exchange for deferred offering costs 25,000       25,000      
Fair value of EBC Founder Shares charged to deferred offering costs 130,550              
Allocation of offering costs to ordinary shares subject to redemption 3,974,257       3,974,257      
Allocation of offering costs to ordinary shares subject to possible redemption 3,722,527       3,722,527      
Initial classification of ordinary shares subject to redemption to temporary equity 59,280,000       59,280,000      
Accretion of additional paid in capital to accumulated deficit 4,694,257       4,694,257      
Contribution of transaction cost         280,725      
Subsequent measurement of ordinary shares subject to possible redemption 56,234         1,924,226      
Extension funds attributable to ordinary shares subject to redemption         600,000      
Investment of cash in Trust Account         (60,000,000)        
Proceeds from issuance of EBC Founders Share         1,450        
Payment of offering costs         (266,978)        
Fair value of EBC Founder Shares charged to deferred offering costs         130,550        
Forfeiture of ordinary shares         23        
Accretion of subsequent measurement of ordinary shares subject to possible redemption         752,079        
North Water Investment Group Holdings Limited [Member]                  
Cash flows from operating activities:                  
Net income             432,828 $ 3,347,275 $ (1,074,799)
Adjustment to reconcile net income to cash used in operating activities:                  
Deprecation of plant and equipment             923 7,141 1,678
Allowance for expected credit losses             8,698 67,263
Unrealized fair value change of financial instruments held, at fair value             28 217 (787)
Interest income             (1,345) (10,405) (309,016)
Dividend income             (52)
Plant and equipment written off             7,306 56,500
Change in operating assets and liabilities:                  
Change in receivables from customers             (28,504) (220,433) (53,101)
Change in deposits and other receivables             48,782 377,258 52,616
Change in operating lease right-of-use assets             (450,838) (3,486,556)
Change in other non-current assets             (81,627) (631,260)
Change in payables to customers             18,729 144,842 (1,375,656)
Change in accruals and other current liabilities             4,070 31,477 (4,918)
Change in contract liabilities             3,879 30,000
Change in operating lease liabilities             450,095 3,480,807
Change in amount due to a director             1,265 9,783
Change in prepaid expenses             (29,600) (228,912) 6,216
Net cash provided by operating activities             384,689 2,974,997 (2,757,819)
Cash flows from investing activities:                  
Purchases of plant and equipment             (16,293) (126,004)
Advance to a shareholder             (387,923) (3,000,000)
Repayment from a shareholder             387,923 3,000,000
(Placement) withdrawal of term deposits             1,939,613 15,000,000 (15,000,000)
Net cash (used in) provided by investing activities             1,923,320 14,873,996 (15,000,000)
Cash flows from financing activities:                  
Proceeds from issue of shares             30,000,000
Payment for reduction of shares             (3,879,227) (30,000,001)
Net cash provided by (used in) financing activities             (3,879,227) (30,000,001) 30,000,000
Net change in cash, cash equivalents and restricted cash             (1,571,218) (12,151,008) 12,242,181
Cash, cash equivalents and restricted cash at beginning of the year   1,312,219 $ 10,148,046 $ 22,299,054   1,312,219 2,883,437 22,299,054 10,056,873
Cash, cash equivalents and restricted cash at end of the year         1,312,219   1,312,219 10,148,046 22,299,054
Cash, cash equivalents and restricted cash:                  
Cash and cash equivalents         819,961   819,961 6,341,165 18,644,879
Cash-segregated for regulatory purpose         492,258   492,258 3,806,881 3,654,175
Supplementary cash flows information:                  
Cash received from interest             87,980 680,391 420,541
Cash paid for income taxes            
Mango Financial Group Limited [Member]                  
Cash flows from operating activities:                  
Net income   497,800 3,892,810 4,507,888          
Adjustment to reconcile net income to cash used in operating activities:                  
Deprecation of plant and equipment   1,754 13,720 839       7,141  
Allowance for expected credit losses            
Unrealized fair value change of financial instruments held, at fair value   (7) (58) 254          
Deposit written off   4,604 36,000          
Change in operating assets and liabilities:                  
Change in receivables from customers   (139,336) (1,089,611) (20,255)          
Change in deposits and other receivables   (3,109) (24,314) 309,000          
Change in operating lease right-of-use assets   117,137 916,009          
Change in payables to customers   6,607,874 51,673,575 166,025          
Change in accruals and other current liabilities   155,752 1,217,979 (37,168)          
Change in contract liabilities   816,357 6,383,915 210,000          
Change in operating lease liabilities   (119,601) (935,280)          
Change in amount due to a director   1,279 10,000          
Change in prepaid expenses   (752,793) (5,886,842) 2,763          
Net cash provided by operating activities   7,187,711 56,207,903 5,139,346          
Cash flows from investing activities:                  
Purchases of plant and equipment   (5,083) (39,749)          
Advance to a shareholder   (3,000,000)          
Repayment from a shareholder   3,000,000          
(Placement) withdrawal of term deposits   15,000,000          
Net cash (used in) provided by investing activities   (5,083) (39,749) 15,000,000          
Cash flows from financing activities:                  
Proceeds from issue of shares   1,278,772 10,000,000          
Payment for reduction of shares   (23,000,000)          
Payment of deferred offering costs   (406,093) (3,175,646)          
Net cash provided by (used in) financing activities   872,679 6,824,354 (23,000,000)          
Net change in cash, cash equivalents and restricted cash   8,055,307 62,992,508 (2,860,654)          
Cash, cash equivalents and restricted cash at beginning of the year   1,297,705 10,148,046 22,299,054   $ 1,297,705   22,299,054  
Cash, cash equivalents and restricted cash at end of the year   9,353,012 73,140,554 19,438,400 $ 1,297,705   $ 1,297,705 10,148,046 $ 22,299,054
Cash, cash equivalents and restricted cash:                  
Cash and cash equivalents   2,259,198 17,666,926 15,623,276       6,341,165  
Cash-segregated for regulatory purpose   7,093,814 55,473,628 3,815,124       $ 3,806,881  
Supplementary cash flows information:                  
Cash received from interest   11,091 86,734 209,905          
Cash paid for income taxes